Newcells Biotech

The company specializes in the manufacture of human induced pluripotent stem cell (iPSC) derived cells and provides laboratory services including gene editing, reprogramming, and cell banking. They develop physiologically relevant in vitro systems for drug discovery and disease research, focusing on neuroscience, ophthalmology, dermatology, and cardiovascular sectors. Their target market includes global pharmaceutical companies, contract research organizations, biotechnology firms, and academic institutions.